Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
Atara Biotherapeutics
Genzada Pharmaceuticals USA, Inc.
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Chicago
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Louisville
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
University of Rochester
Alliance for Clinical Trials in Oncology
Morphotek
Columbia University
National Cancer Institute (NCI)
Mayo Clinic
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boston Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)